Rami Burstein1, Pamela Blake, Aaron Schain, Carlton Perry. 1. aDepartment of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center bDepartment of Anesthesia, Harvard Medical School, Boston, Massachusetts cHeadache Center of Greater Heights, Memorial Hermann Medical Group dRiver Oaks Plastic Surgery Center, Houston, Texas, USA.
Abstract
PURPOSE OF REVIEW: To summarize recent clinical and preclinical studies on extracranial pathophysiologies in migraine. It challenges the opinion-based notion that the headache phase of migraine occurs without input from peripheral nociceptors or is caused solely by activation of intracranial nociceptors supplying dural and cerebral vasculature. RECENT FINDINGS: Data that support a scenario by which migraine can originate extracranially include the perception of imploding headache that hurts outside the cranium, the existence of a network of sensory fibers that bifurcate from parent axons of intracranial meningeal nociceptors and reach extracranial tissues such as periosteum and pericranial muscles by crossing the calvarial bones through the sutures, the discovery of proinflammatory genes that are upregulated and anti-inflammatory genes that are down regulated in extracranial tissue of chronic migraine patients, and evidence that administration of OnabotulinumtoxinA to peripheral tissues outside the calvaria reduces frequency of migraine headache. SUMMARY: These findings seeks to shift clinical practice from prophylactically treating chronic migraine solely with medications that reduce neuronal excitability to treating irritated nociceptors or affected tissues. The findings also seeks to shift current research from focusing solely on central nervous system alterations and activation of meningeal nociceptors as a prerequisite for studying migraine.
PURPOSE OF REVIEW: To summarize recent clinical and preclinical studies on extracranial pathophysiologies in migraine. It challenges the opinion-based notion that the headache phase of migraine occurs without input from peripheral nociceptors or is caused solely by activation of intracranial nociceptors supplying dural and cerebral vasculature. RECENT FINDINGS: Data that support a scenario by which migraine can originate extracranially include the perception of imploding headache that hurts outside the cranium, the existence of a network of sensory fibers that bifurcate from parent axons of intracranial meningeal nociceptors and reach extracranial tissues such as periosteum and pericranial muscles by crossing the calvarial bones through the sutures, the discovery of proinflammatory genes that are upregulated and anti-inflammatory genes that are down regulated in extracranial tissue of chronic migrainepatients, and evidence that administration of OnabotulinumtoxinA to peripheral tissues outside the calvaria reduces frequency of migraine headache. SUMMARY: These findings seeks to shift clinical practice from prophylactically treating chronic migraine solely with medications that reduce neuronal excitability to treating irritated nociceptors or affected tissues. The findings also seeks to shift current research from focusing solely on central nervous system alterations and activation of meningeal nociceptors as a prerequisite for studying migraine.
Authors: W Gong; O M Howard; J A Turpin; M C Grimm; H Ueda; P W Gray; C J Raport; J J Oppenheim; J M Wang Journal: J Biol Chem Date: 1998-02-20 Impact factor: 5.157
Authors: Julia A Files; Todd J Schwedt; Anita P Mayer; Paru S David; Bert B Vargas; Yu-Hui Chang; Megan Hunt; Salma Patel; Marcia G Ko; Beverly S Tozer; Rami Burstein; David W Dodick Journal: Headache Date: 2014-04-25 Impact factor: 5.887
Authors: Eva B Niklinska; Juan M Colazo; James Randall Patrinely; Brian C Drolet; Salam A Kassis Journal: Plast Surg (Oakv) Date: 2021-04-27 Impact factor: 0.558
Authors: Arnaud J P E Vincent; Willem S van Hoogstraten; Antoinette Maassen Van Den Brink; Joost van Rosmalen; Bibi L J Bouwen Journal: Front Neurol Date: 2019-02-14 Impact factor: 4.003
Authors: Andreas Leonard Amons; Rene Franciscus Castien; Johannes C van der Wouden; Willem De Hertogh; Joost Dekker; Henriëtte Eveline van der Horst Journal: Trials Date: 2019-12-27 Impact factor: 2.279